兽用疫苗市场规模、份额及成长分析（按类型、疾病、技术、给药途径、最终用户和地区）－2025-2032 年产业预测

2023 年全球动物疫苗市场规模为 86 亿美元，预计将从 2024 年的 92.1 亿美元成长到 2032 年的 159.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.1%。

全球兽用疫苗市场正在经历强劲增长，这得益于人们对动物健康的认识不断提高以及对肉类、牛奶和蛋类等动物衍生产品的需求不断增长。通用感染疾病的增加凸显了预防措施的必要性，并进一步凸显了粮食安全的关键作用。牲畜数量的增加以及对食品安全和永续性的日益重视正在推动市场扩张。疫苗有效性和安全性方面的创新正在获得兽医和宠物饲主的支持。此外，产业巨头对研发的大量投资，加上开发中国家政府针对预防和根除动物疾病的倡议，正在推动市场成长。动物疾病发生率的上升和畜牧业（尤其是家禽）的扩张是市场动态的主要影响因素。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 技术分析
• 案例研究
• 客户和购买标准分析

动物疫苗市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 牲畜疫苗
  • 牛疫苗
  • 小反刍动物疫苗
• 猪疫苗
• 家禽疫苗
• 宠物疫苗
  • 狗狗疫苗
  • 猫疫苗
• 水产养殖疫苗
• 其他动物疫苗

动物疫苗市场规模（依疾病区分）及复合年增长率（2025-2032）

• 市场概览
• 牲畜疾病
  • 牛病
  • 小反刍动物疾病
• 猪病
• 家禽疾病
• 宠物疾病
  • 狗的疾病
  • 猫病
• 水产养殖疾病
• 其他兽医疾病

动物疫苗市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 减毒活疫苗
• 灭活疫苗
• 类毒素疫苗
• 重组疫苗
• 其他疫苗技术

动物疫苗市场规模（依给药途径和复合年增长率） (2025-2032)

• 市场概览
• 皮下途径
• 肌肉注射
• 口服途径
• 鼻内/喷雾给药途径
• 眼内途径
• 其他给药途径

动物疫苗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 兽医诊所
• 兽医诊所
• 其他最终用户

动物疫苗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Zoetis, Inc.（US）
• Merck & Co, Inc.（US）
• Boehringer Ingelheim International GmbH（Germany）
• Elanco Animal Health（US）
• Virbac（France）
• Hester Biosciences Limited（India）
• Neogen Corporation（US）
• HIPRA（Spain）
• Biogenesis Bago（Argentina）
• Tianjin Ringpu Bio-Technology Co Ltd.（China）
• China Animal Husbandry Group（China）
• Jinyu Bio-technology（China）
• Vaxxinova International BV（Netherlands）
• Endovac Animal Health（US）
• Brilliant Bio Pharma（India）
• Aptimmune（US）
• Indian Immunologicals Ltd.（India）
• Torigen Pharmaceuticals, Inc.（US）
• VEROVACCiNES GmbH（Germany）
• Intas Pharmaceuticals（India）
• Ourofino Animal Health（Brazil）
• Biovac（Israel）
• Laboratoire LCV（France）

结论和建议

Global Veterinary Vaccines Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.21 billion in 2024 to USD 15.94 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global veterinary vaccines market is experiencing robust growth, fueled by heightened awareness of animal health and rising demand for animal-derived products like meat, milk, and eggs. The increasing incidence of zoonotic diseases has underscored the necessity of preventative measures, further highlighting the critical role of food security. A growing livestock population, alongside heightened emphasis on food safety and sustainability, drives market expansion. Innovations in vaccine efficacy and safety are gaining traction among veterinarians and pet owners. Additionally, significant investments from industry leaders in research and development, combined with government initiatives in developing countries targeting the prevention and eradication of animal diseases, are accelerating market growth. The rising prevalence of animal diseases and expanding livestock sectors, particularly poultry, contribute significantly to market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases, Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rise in zoonotic diseases, which are illnesses that can be transmitted from animals to humans. The increasing prevalence of diseases such as rabies, avian influenza, and swine flu has led to a heightened demand for veterinary vaccines. By vaccinating domestic animals against these diseases, the risk of transmission to humans is mitigated, thereby enhancing public health and preventing potential outbreaks. Furthermore, global population growth and the shifting dietary preferences towards increased animal protein consumption, particularly in developing nations, have escalated the demand for livestock. This surge in interest and concern for animal health has resulted in a substantial expansion of the veterinary vaccines market.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant constraints due to the intricate and prolonged process of developing and producing new vaccines, which involves extensive research, clinical trials, and regulatory approvals. The high costs associated with both the development and manufacturing of vaccines can render them unaffordable for many farmers and pet owners, particularly in resource-limited areas. Additionally, the expenses involved in ensuring proper storage and transportation under required conditions further increase the overall costs of vaccination. These financial barriers can hinder the widespread adoption of veterinary vaccines and inhibit market growth, especially in developing regions.

Market Trends of the Global Veterinary Vaccines Market

A significant trend in the Global Veterinary Vaccines market is the rising adoption of recombinant vaccines, leveraging advanced biotechnological methods for heightened efficacy and targeted protection against specific pathogens. These vaccines, designed as hybrids, not only enhance immunogenicity but also reduce the likelihood of adverse reactions, making them increasingly favored by veterinarians and pet owners alike. This shift aligns with a broader trend toward personalized medicine in veterinary care, as stakeholders seek innovative solutions that deliver improved health outcomes for animals. As awareness of these benefits grows, the demand for recombinant vaccines is expected to drive market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2025-2032)

• Market Overview
• Livestock Vaccines
  • Bovine Vaccines
  • Small Ruminant Vaccines
• Porcine Vaccines
• Poultry Vaccines
• Companion Animal Vaccines
  • Canine Vaccines
  • Feline Vaccines
• Aquaculture Vaccines
• Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Livestock Diseases
  • Bovine Diseases
  • Small Ruminant Diseases
• Porcine Diseases
• Poultry Diseases
• Companion Animal Diseases
  • Canine Diseases
  • Feline Diseases
• Aquaculture Diseases
• Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2025-2032)

• Market Overview
• Subcutaneous Route of Administration
• Intramuscular Route of Administration
• Oral Route of Administration
• Intranasal/Spray Route of Administration
• Intraocular Route of Administration
• Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Other End Users

Global Veterinary Vaccines Market Size & CAGR (2025-2032)

• North America (Type, Disease, Technology, Route Of Administration, End User)
  • US
  • Canada
• Europe (Type, Disease, Technology, Route Of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Disease, Technology, Route Of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tianjin Ringpu Bio-Technology Co Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Animal Husbandry Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinyu Bio-technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endovac Animal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brilliant Bio Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aptimmune (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torigen Pharmaceuticals, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VEROVACCiNES GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Animal Health (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biovac (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire LCV (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations